Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
CALL
Accenture
ACN
$114B
| $510K | ﹤0.01% |
+2,900
| New | +$456K |
|
|
3227
PUT
Accenture
ACN
$114B
| $510K | ﹤0.01% |
+2,900
| New | +$456K |
|
|
LX
3228
LexinFintech Holdings
LX
$213M
| $510K | ﹤0.01% |
+48,600
| New | +$495K |
|
3229
AudioCodes
AUDC
$238M
| $508K | ﹤0.01% |
36,677
-259,659
| -88% | -$3.42M |
|
3230
Fastenal
FAST
$58.3B
| $506K | ﹤0.01% |
31,488
-3,331,604
| -99% | -$50.1M |
|
3231
TransDigm Group
TDG
$65.6B
| $506K | ﹤0.01% |
+1,114
| New | +$452K |
|
|
CHSP
3232
DELISTED
Chesapeake Lodging Trust
CHSP
| $506K | ﹤0.01% |
18,191
-3,365
| -16% | -$94.9K |
|
|
EVN
3233
Eaton Vance Municipal Income Trust
EVN
$431M
| $505K | ﹤0.01% |
+41,400
| New | +$486K |
|
3234
Genesco
GCO
$378M
| $505K | ﹤0.01% |
11,087
-27,373
| -71% | -$1.25M |
|
3235
Innovative Industrial Properties
IIPR
$1.57B
| $505K | ﹤0.01% |
+6,186
| New | +$418K |
|
3236
iShares International Select Dividend ETF
IDV
$8.69B
| $503K | ﹤0.01% |
16,300
-11,691
| -42% | -$361K |
|
|
MRSN
3237
DELISTED
Mersana Therapeutics
MRSN
| $503K | ﹤0.01% |
3,829
+2,059
| +116% | +$259K |
|
3238
Annaly Capital Management
NLY
$17.3B
| $503K | ﹤0.01% |
+12,600
| New | +$514K |
|
3239
CALL
AT&T
T
$176B
| $502K | ﹤0.01% |
+21,184
| New | +$487K |
|
|
3240
PUT
AT&T
T
$176B
| $502K | ﹤0.01% |
+21,184
| New | +$487K |
|
|
NTUS
3241
DELISTED
Natus Medical Inc
NTUS
| $502K | ﹤0.01% |
+19,777
| New | +$590K |
|
|
QHC
3242
DELISTED
Quorum Health Corporation
QHC
| $502K | ﹤0.01% |
+358,511
| New | +$965K |
|
3243
ANI Pharmaceuticals
ANIP
$1.71B
| $500K | ﹤0.01% |
7,085
-3,746
| -35% | -$220K |
|
|
TVRD
3244
Tvardi Therapeutics
TVRD
$24.3M
| $500K | ﹤0.01% |
708
-8,024
| -92% | -$4.8M |
|
3245
Lifecore Biomedical
LFCR
$181M
| $499K | ﹤0.01% |
+40,671
| New | +$497K |
|
|
NHS
3246
Neuberger High Yield Strategies Fund Inc
NHS
$249M
| $499K | ﹤0.01% |
+44,200
| New | +$480K |
|
|
TTM
3247
DELISTED
Tata Motors Limited
TTM
| $499K | ﹤0.01% |
+39,715
| New | +$496K |
|
3248
Vanguard Financials ETF
VFH
$13.9B
| $495K | ﹤0.01% |
7,669
-920
| -11% | -$59.7K |
|
|
SRNE
3249
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $495K | ﹤0.01% |
+104,217
| New | +$273K |
|
|
TGH
3250
DELISTED
Textainer Group Holdings limited
TGH
| $494K | ﹤0.01% |
51,150
+35,297
| +223% | +$419K |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.